The PTFE Guide Wire segmentation by application is anchored in four primary domains: cardiology, radiology, surgery, and ancillary uses. Cardiology, representing roughly 40 % of total revenue, leverages the wire’s low friction and high torque transmission for coronary interventions, where precision and maneuverability directly affect procedural success rates. Radiology accounts for about 30 % and utilizes the guide wire in endovascular embolization and image‑guided biopsies, where PTFE’s radiolucency minimizes artifact generation. Surgical applications, contributing an estimated 20 %, include peripheral vascular access and minimally invasive orthopedic procedures, capitalizing on the wire’s biocompatibility and resistance to kinking. The remaining 10 % falls under “others,” encompassing niche markets such as neuro‑interventional and urological procedures, where specialized sub‑types (e.g., hydrophilic‑coated or stainless‑steel core variants) address unique anatomical constraints. Collectively, these application segments delineate demand drivers, with each proportion reflecting both procedural volume and the premium placed on PTFE’s mechanical and chemical stability within the overall PTFE Guide Wire market size.
